Company Name NxThera
Mailing Address 7351 Kirkwood Lane N Maple Grove, MN 55369
Company Description NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company’s technology platform utilizes a simple, minimally invasive, vapor therapy designed to measurably improve urinary flow and patient quality of life.
Proceeds Purposes NxThera will use this Series C capital to (i) conduct a U.S. clinical trial to seek FDA clearance to market its Rezum System to treat BPH, (ii) begin targeted, early commercialization of its Rezum System in selected European countries in 2014, and (iii) expand its applied research and feasibility studies to evaluate applications of its sterile water vapor technology to treat prostate cancer and kidney cancer.